Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001062993-19-003653
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-09-10 21:22:18
Reporting Period:
2019-09-09
Accepted Time:
2019-09-10 21:22:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875622 Biospecifics Technologies Corp BSTC Pharmaceutical Preparations (2834) 113054851
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1405128 Toby Wegman C/o Biospecifics Technologies Corp.
35 Wilbur Street
Lynbrook NY 11563
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Disposition 2019-09-09 1,100 $55.23 943,973 No 4 S Indirect See footnote
Common Stock, $0.001 Par Value Disposition 2019-09-10 8,900 $55.16 935,073 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See footnote
No 4 S Indirect See footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock, $0.001 Par Value 1,890 Direct
Footnotes
  1. The selling price of $55.23 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $55.20 to $55.35. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  2. The selling price of $55.16 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $55.00 to $55.44. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
  3. These shares are held in trust on behalf of the reporting person. The reporting person is the trustee of the trust. The reporting person disclaims beneficial ownership of the shares held by the trust except to the extent of the reporting person's pecuniary interest therein.